您当前所在的位置:首页 > 产品中心 > 产品信息
Verapamil_分子结构_CAS_52-53-9)
点击图片或这里关闭

Verapamil

产品号 Bio-0754 公司名称 InterBioScreen
CAS号 52-53-9 公司网站 http://www.ibscreen.com
分子式 C27H38N2O4 电 话 +7 49652 40091
分子量 454.60162 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 543

产品价格信息

请登录

产品别名

标题
Verapamil
IUPAC标准名
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
IUPAC传统名
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
别名
Calan
Geangin
Iproveratril
Isoptin
Vasolan
Verelan
Berkatens
Cordilox
Covera
Ethimil
Securon
Univer
Verapress

产品登记号

CAS号 52-53-9

产品性质

应用领域 Antiarrhythmic (class IV) agent
应用领域 Coronary vasodilator
应用领域 Smooth muscle relaxant.
应用领域 Used in the treatment of hypertension, angina pectoris, cardiac arrhythmia, and cluster headaches.
生物活性机理 Calcium antagonist
生物活性机理 Inhibits movement of calcium ions across the cell membrane
生物活性机理 Protein kinase C inhibitor

产品详细信息

参考文献

  • Knoll, A.G., Angew. Chem., Int. Ed., 1964, 3, 68, (synth, pharmacol)
  • Ramuz, H., Helv. Chim. Acta, 1975, 58, 2050, (synth, ir, ms, pmr, abs config)
  • Ger. Pat., 1978, 2 631 222; CA, 88, 169796, (synth)
  • Baky, S.H. et al., Pharmacol. Biochem. Prop. Drug Subst., 1981, 3, 226, (rev, pharmacol)
  • Guerrero, J.R. et al., Med. Res. Rev., 1984, 4, 87, (rev)
  • Carpy, A. et al., Acta Cryst. C, 1985, 41, 624, (cryst struct)
  • Larangh, J.H., Am. J. Cardiol., Ed., Part 7, 1986, 57, (book)
  • Echizen, H. et al., Clin. Pharmacokinet., 1986, 11, 425, (rev)
  • Theodore, L.J. et al., J.O.C., 1987, 52, 1309, (synth)
  • Chang, Z.L., Anal. Profiles Drug Subst., 1988, 17, 643, (rev)
  • Scheid, W. et al., Arzneim.-Forsch., 1991, 41, 901, (tox)
  • Hofer, C.A. et al., Am. J. Med., 1993, 95, 431, (tox)
  • Longstreth, J.A., Drug Stereochem., (Ed. Wainer, I.W.), M. Dekker, 1993, 315, (rev)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 7th edn., Akademie-Verlag, 1994, 10669; 10670
  • Brogden, R.N. et al., Drugs, 1996, 51, 792, (rev)
  • Dooley, M. et al., Drugs, 1998, 56, 837-844, (rev)
  • Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 960
  • Bannister, R.M. et al., Org. Process Res. Dev., 2000, 4, 467-472, (synth, pmr)
  • Brenna, E. et al., Eur. J. Org. Chem., 2001, 1349-1357, (synth)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, IRV000; VHA450